Effect of oil-based moisturizer with breast cancer patients who would experience skin dryness due to chemotherapy

Effect of oil-based moisturizer with breast cancer patients who would experience skin dryness due to chemotherapy: 3 arms randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001372

Enrollment

204

Registered

2015-02-04

Start date

2015-02-16

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Intervention – Oil based moisturizer (start: After 1cycle of chemotherapy/ end: 1month after the completion of chemotherapy ) Control 1 – General moisturizer (start: After 1cycle of chemothe

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with postoperative stage I to III cancer, and who were expected to receive doxorubicin plus cyclophosphamide (AC), fluorouracil plus cyclophosphamide and doxorubicin (FAC), or taxane as adjuvant chemotherapy. Among the patients, we will recruit patients without skin dryness before chemotherapy and increased skin dryness after 1 cycle of chemotherapy.. Also patients should visit to measure baseline skin status.

Exclusion criteria

Exclusion criteria: Patients who had dermatological problem such as atopic dermatitis, psoriasis, or infectious diseases, or who were taking steroids or antihistamines or had sensitive skinhttps://cris.nih.go.kr/cris/write/step9.jsp?seq=6665&mod=m#removeAll

Design outcomes

Primary

Measure	Time frame
Patient reported dryness	—

Secondary

Measure	Time frame
Sebum content	—

Countries

Korea, Republic of

Contacts

Public ContactDanbee Kang

Sungkyunkwan University

dbee.kang@gmail.com+82-2-6007-5456

Outcome results